Connable Office Inc
AZN icon

Connable Office Inc’s AstraZeneca AZN Stock Holding History

Connable Office Inc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$504K Sell
3,123
-2,725
-47% -$454K 0.04% 138
2026
Q2 		$1.11M Sell
5,848
-96
-2% -$18.1K 0.1% 88
2026
Q1 		$1.17M Buy
5,944
+183
+3% +$35.3K 0.12% 80
2025
Q4 		$1.06M Sell
5,761
-247
-4% -$43.3K 0.1% 89
2025
Q3 		$922K Hold
6,008
– – 0.09% 95
2025
Q2 		$840K Sell
6,008
-4,026
-40% -$564K 0.08% 101
2025
Q1 		$1.47M Sell
10,034
-555
-5% -$80.3K 0.16% 80
2024
Q4 		$1.39M Sell
10,589
-293
-3% -$41K 0.14% 81
2024
Q3 		$1.7M Hold
10,882
– – 0.17% 78
2024
Q2 		$1.7M Buy
10,882
+2,661
+32% +$400K 0.18% 78
2024
Q1 		$1.11M Sell
8,221
-280
-3% -$37.1K 0.13% 88
2023
Q4 		$1.15M Hold
8,501
– – 0.14% 86
2023
Q3 		$1.15M Buy
8,501
+21
+0.2% +$2.87K 0.16% 85
2023
Q2 		$1.21M Sell
8,480
-206
-2% -$30.3K 0.17% 82
2023
Q1 		$1.21M Hold
8,686
– – 0.18% 84
2022
Q4 		$1.18M Buy
8,686
+73
+0.8% +$9.16K 0.17% 84
2022
Q3 		$945K Buy
+8,613
New +$1.09M 0.15% 91
2014
Q2 		– Sell
-4,138
Closed -$268K – 216
2014
Q1 		$268K Sell
4,138
-742
-15% -$47.9K 0.07% 155
2013
Q4 		$290K Sell
4,880
-491
-9% -$26.7K 0.08% 147
2013
Q3 		$279K Hold
5,371
– – 0.08% 185
2013
Q2 		$254K Buy
+5,371
New +$273K 0.07% 186

Other funds holding AZN

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Connable Office Inc's AZN Position: Q3 2026 in Review

Connable Office Inc reduced its AstraZeneca (AZN) stake by 47% in Q3 2026, selling an estimated $454K and leaving 3,123 shares worth $504K. The position accounts for 0.04% of the portfolio, ranked #138.

Connable Office Inc first reported a position in AZN in Q2 2013 and has held it in 21 quarters since. The position peaked at $1.7M in Q2 2024. 1,103 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Connable Office Inc held 3,123 shares of AstraZeneca worth $504K as of Q3 2026.
  • Connable Office Inc sold 2,725 AstraZeneca shares in Q3 2026, an estimated $454K.
  • AstraZeneca made up 0.04% of Connable Office Inc's portfolio in Q3 2026, its #138 holding.
  • Connable Office Inc first reported a position in AstraZeneca in Q2 2013 and has held it in 21 quarters since.
  • Connable Office Inc's AstraZeneca position peaked at $1.7M in Q2 2024.
  • 1,103 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Connable Office Inc's 13F filing for Q3 2026, filed 10 Nov 2026.